Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults.
Cell Res
; 32(8): 777-780, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-1890164
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Topics:
Vaccines
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Cell Res
Year:
2022
Document Type:
Article
Affiliation country:
S41422-022-00681-3
Similar
MEDLINE
...
LILACS
LIS